BridgeBio Pharma (BBIO) Retained Earnings (2018 - 2026)
BridgeBio Pharma (BBIO) posted Retained Earnings of -$4.0 billion for Q1 2026, down 293.68% sequentially from $2.1 billion in Q4 2025.
BridgeBio Pharma (BBIO) Retained Earnings (2018 - 2026) Analysis & Trends
BridgeBio Pharma has reported Retained Earnings for 9 years, with the latest figure at -$4.0 billion in Q1 2026.
- Quarterly Retained Earnings changed N/A year-over-year to -$4.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 billion (changed N/A YoY) and the FY2025 annual result came in at $2.1 billion, up 25720475.0% from the prior year.
- Retained Earnings declined to -$4.0 billion in Q1 2026 per BBIO's latest filing, from $2.1 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $2.1 billion in Q4 2025 and troughed at -$4.0 billion in Q1 2026.
- A 5-year average of -$1.5 billion and a median of -$1.7 billion in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 25720475.0% in 2025, down 86139600.0% in 2025.
- Over 5 years, Retained Earnings stood at -$328000.0 in 2022, then slumped by 780540.55% to -$2.6 billion in 2023, then soared by 100.0% to $8000.0 in 2024, then surged by 25720475.0% to $2.1 billion in 2025, then sank by 293.68% to -$4.0 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$4.0 billion, $2.1 billion, and -$3.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn | -4.14 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.14 Bn |
| Mar 31, 2026 | -3.99 Bn |
| Dec 31, 2025 | 2.06 Bn |
| Sep 30, 2025 | -3.63 Bn |
| Jun 30, 2025 | -3.45 Bn |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -2.56 Bn |
| Sep 30, 2023 | -2.39 Bn |
| Jun 30, 2023 | -2.22 Bn |
| Mar 31, 2023 | -2.06 Bn |
| Dec 31, 2022 | -328,000.00 |
| Sep 30, 2022 | -1.78 Bn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -1.63 Bn |
| Dec 31, 2021 | -132,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 36,000.00 |